ARCHIVES

41 CCOPs Reported For Recompetition

This article is from The Cancer Letter archive.

Vol. 16 No. 08 | February 23, 1990

Download PDF Visit The Full Archive

Related Articles

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Michael Link Elected ASCO President.

January 15, 2010

Conversation with The Cancer Letter: Daniel Hayes Leads Tour of Caris Website

August 8, 2014

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

June 25, 2010

FA Drug Approval on Activity, Rather Than Survival Urged By NCU

January 13, 1989

Three Congressmen Back Straus Demand For Single Probe

August 28, 1981